4
Changes in Ownership
TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-20-009052
Options or other derivatives
- Exec. VP Chief Legal Officer acquired 13,090 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Stark David Matthew · Exec. VP Chief Legal Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-02-11 | Grant or award : show line 1 in the form Restricted Share Units | +13,090 | 13,090 | D |
Loading xslF345X03/doc4.xml…